Skip to main content
Europlasma logo

Europlasma — Investor Relations & Filings

Ticker · ALEUP ISIN · FR001400CF13 LEI · 969500WYVNHBV1ABQ250 Euronext Growth Water supply; sewerage, waste management and remediation activities
Filings indexed 504 across all filing types
Latest filing 2026-01-28 Capital/Financing Update
Country FR France
Listing Euronext Growth ALEUP

Europlasma is a company specializing in clean technology and energy solutions. Its core activities focus on the research, engineering, and application of plasma solutions for industrial purposes, particularly for the treatment of hazardous waste and gas. The company provides services for the destruction and valorization of asbestos waste. In the decarbonization sector, Europlasma transforms waste into Solid Recovered Fuel (SRF). Additionally, the company operates an industrial division that manufactures hollow bodies and anodized sheets for capacitors.

Recent filings

Filing Released Lang Actions
EUROPLASMA: Tirage de 400 obligations convertibles en actions nouvelles pour un montant nominal de 2M
Capital/Financing Update Classification · 100% confidence The document is a press release from Europlasma announcing the issuance of convertible bonds (OCA) to raise capital. It details the specific tranches, the legal framework, and the potential dilutive impact on shareholders. This falls under the category of capital and financing updates, as it describes a specific fundraising activity rather than a general regulatory filing or a periodic report.
2026-01-28 French
EUROPLASMA: Europlasma fait un point sur la situation de Fonderie de Bretagne
Regulatory Filings Classification · 95% confidence The document is a press release issued by Europlasma on January 23, 2026. It addresses specific operational updates (a fire at a subsidiary, Fonderie de Bretagne), refutes media rumors regarding internal investigations, and provides a status update on financial commitments and industrial progress. While it contains financial information, it is not a formal financial report (10-K or IR) nor a standalone audit report. It functions as a general corporate announcement regarding company operations and regulatory matters, which fits the 'Regulatory Filings' (RNS) category for miscellaneous corporate communications that do not fall into more specific categories like M&A or dividend announcements.
2026-01-23 French
EUROPLASMA: Europlasma fait un point sur la situation de Fonderie de Bretagne
Regulatory Filings Classification · 95% confidence The document is a press release issued by Europlasma regarding an operational incident (fire) at a subsidiary, a denial of media rumors, and a status update on financial commitments. It is a corporate announcement providing material information to the public and shareholders. It does not fit into specific categories like financial reports, proxy statements, or audit reports. Therefore, it is classified as a general regulatory announcement (RNS).
2026-01-23 French
EUROPLASMA: Fonderie de Bretagne franchit une étape clé dans sa diversification vers l’industrie de la défense
Regulatory Filings Classification · 95% confidence The document is a press release issued by Europlasma regarding a specific operational milestone (successful fragmentation tests) for its subsidiary, Fonderie de Bretagne, in the defense sector. It does not contain full financial statements, audit reports, or meeting minutes. It is a standard corporate announcement regarding business activities and strategic progress, which falls under the 'Regulatory Filings' (RNS) category as a general corporate announcement.
2026-01-19 French
EUROPLASMA: Fonderie de Bretagne franchit une etape cle dans sa diversification vers lindustrie de la defense
Regulatory Filings Classification · 95% confidence The document is a press release issued by Europlasma regarding a operational milestone (qualification of products for the defense industry) at its subsidiary, Fonderie de Bretagne. It is a standard corporate news announcement detailing business progress rather than a formal financial report, audit, or proxy statement. As it does not fit into specific categories like M&A, dividends, or director dealings, it falls under the general regulatory announcement category.
2026-01-19 French
EUROPLASMA: Tirage de 200 obligations convertibles en actions nouvelles pour un montant nominal de 1M
Capital/Financing Update Classification · 100% confidence The document is a press release from Europlasma announcing the issuance of 200 convertible bonds for a nominal amount of 1 million euros. This is a direct announcement of a capital financing activity involving convertible debt instruments. It details the legal framework, the dilution risks, and the impact on shareholders, which aligns perfectly with the 'Capital/Financing Update' category. It is not a report publication announcement (RPA) because it provides the specific details of the transaction itself rather than just announcing the availability of a report.
2026-01-06 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.